Trailhead Biosystems Inc. ( a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding ...

Additional funding of $20 million accelerates commercialization of Trailhead's iPSC-derived human cell and media products.

Researchers at the University of British Columbia developed a reliable method to produce helper T cells from stem cells by ...

The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...

For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...

NewcelX Ltd. ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine solutions, today reported the results of an international collaborative research study ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Explore how stressors during pregnancy influence foetal brain development and the impact on future neurodevelopmental ...

WPR, one of the largest independently owned PR and digital marketing firms in the U.S., today announced it has been selected ...